IVIG Treatment for Refractory Immune-Related Adult Epilepsy

This study has been terminated.
(None of the results appears to have a clear association. Due to futility criteria, impossible to carry out Phase 2 of this study, and phase 1 was terminated.)
Sponsor:
Collaborator:
Baxter Healthcare Corporation
Information provided by (Responsible Party):
Charles M. Epstein, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01545518
First received: November 30, 2011
Last updated: January 5, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)